What’s the recipe for a deal-rich year in global biopharma R&D? A dash of growth, a generous amount of mid-size expansion, equal portions of internal and external innovation, and a pinch of positivity.
What’s the recipe for a deal-rich year in global biopharma R&D? A dash of growth, a generous amount of mid-size expansion, equal portions of internal and external innovation, and a pinch of positivity.
